Gulf Pharmaceutical Industries P.S.C. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was AED 405.3 million compared to AED 419.9 million a year ago. Net loss was AED 41.2 million compared to net income of AED 4.7 million a year ago. Basic loss per share was AED 0.036 compared to basic earnings per share of AED 0.004 a year ago.
For the six months, sales was AED 859.4 million compared to AED 838.5 million a year ago. Net loss was AED 44.1 million compared to net income of AED 6.3 million a year ago. Basic loss per share was AED 0.038 compared to basic earnings per share of AED 0.006 a year ago.